Cardiac Power Output in Cardiogenic Shock Patients
Trial statusRecruiting
Trial phaseEarly Phase 1
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity of Chicago
About this trial
The main purpose of this study is to determine whether differences in myocardial reserve predict clinical outcomes for heart failure patients.
Eligibility criteria
Qualifiers
LVEF ≤ 40%
Evaluation for advanced heart failure therapies, including LVAD, OHT, temporary or long-term inotrope therapy, or counter-pulsation (temporary or long-term with NuPulse device OR
Accurate assessment of invasive hemodynamics due to worsening clinical status, OR
Assessment of myocardial recovery for consideration of LVAD or counter-pulsation (temporary IABP or long-term with NuPulse device) decommissioning or removal OR
Disqualifiers
eGFR < 30 ml/min/1.73 m2
Severe, non-revascularized coronary artery disease
Concurrent acute coronary syndrome
Age < 18 years-old
Trial design
Treatments tested in this trial
- 1:1 Randomization to receive milrinone
Treatment groups
5 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov